PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
26-Feb-2024 Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis Boehringer Ingelheim
23-Feb-2024 How to make sure patients get faster and fairer access to new medicines Association of the British Pharmaceutical Industry (ABPI)
23-Feb-2024 Rare Disease Day: Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA Emmes
22-Feb-2024 UK life science industry sets out priorities for the Budget British Pharmaceutical Industry (ABPI)
22-Feb-2024 EVERSANA CONSULTING Named a Top Consulting Firm in Asia Pacific Region for the Second Consecutive Year EVERSANA
22-Feb-2024 STORM Therapeutics to Present Findings on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at ESMO Targeted Anticancer Therapies Congress STORM Therapeutics Ltd
22-Feb-2024 UKHSA announced as first PACE collaboration to help tackle deadly antimicrobial resistance PACE
22-Feb-2024 KQ Labs announces partnership with Chicago ARC to expand UK data driven health innovations into the U.S. market KQ Labs
22-Feb-2024 2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024 2cureX
22-Feb-2024 ViiV Healthcare and GSK’s Cabenuva could reduce poor treatment adherence in HIV, says GlobalData GlobalData
21-Feb-2024 Polpharma Biologics’ investigational biosimilar shows PK/PD comparability to inflammatory bowel disease blockbuster Entyvio®* Polpharma
21-Feb-2024 Cambridge Cognition and ActiGraph Announce Partnership to Accelerate Adoption of Digital Measurements for Central Nervous System Trials Cambridge Cognition Holdings plc
21-Feb-2024 Cambridge Cognition and ActiGraph Announce Partnership to Accelerate Adoption of Digital Measurements for Central Nervous System Trials Cambridge Cognition Holdings plc
21-Feb-2024 LATITUDE phase III interim trial data indicates ViiV Healthcare’s long-acting injectable HIV treatment Cabenuva (cabotegravir + rilpivirine) has superior efficacy compared to daily therapy in individuals living with HIV who have adherence challenges GSK 
21-Feb-2024 Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program Mestag Therapeutics
20-Feb-2024 Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6 Omnix Medical
19-Feb-2024 GenesisCare Completes Reorganisation and Emerges from Chapter 11 GenesisCare
19-Feb-2024 Oncopeptides ensures five years extended market exclusivity for Pepaxti in Europe Oncopeptides AB
19-Feb-2024 ABPI launches new prescribing support guide for healthcare professionals ABPI
19-Feb-2024 AbbVie Unveils New Data from Robust Gastroenterology Portfolio at the 19th Congress of European Crohn's and Colitis Organisation (ECCO) AbbVie